Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18006157rdf:typepubmed:Citationlld:pubmed
pubmed-article:18006157lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:18006157lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:18006157lifeskim:mentionsumls-concept:C0237865lld:lifeskim
pubmed-article:18006157lifeskim:mentionsumls-concept:C1521970lld:lifeskim
pubmed-article:18006157lifeskim:mentionsumls-concept:C1148926lld:lifeskim
pubmed-article:18006157lifeskim:mentionsumls-concept:C0205171lld:lifeskim
pubmed-article:18006157lifeskim:mentionsumls-concept:C0205349lld:lifeskim
pubmed-article:18006157pubmed:issue1lld:pubmed
pubmed-article:18006157pubmed:dateCreated2007-12-6lld:pubmed
pubmed-article:18006157pubmed:abstractTextThe mechanism behind how PfMDR1 may contribute to antimalarial drug resistance is unclear. Transfection studies suggest that PfMDR1 mutations may make small contributions to drug sensitivity in a strain-dependent fashion, whereas field data link over expression (not necessarily mutation) of the gene with clinical drug treatment failure. This study dissects the contribution of individual mutations of PfMDR1 that contribute to the unique behavior of the 7G8 PfMDR1 isoform. A single mutation in putative TM 11 (S1034C) is found to abolish drug stimulation of PfMDR1 ATPase activity.lld:pubmed
pubmed-article:18006157pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:languageenglld:pubmed
pubmed-article:18006157pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:citationSubsetIMlld:pubmed
pubmed-article:18006157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006157pubmed:statusMEDLINElld:pubmed
pubmed-article:18006157pubmed:monthJanlld:pubmed
pubmed-article:18006157pubmed:issn0166-6851lld:pubmed
pubmed-article:18006157pubmed:authorpubmed-author:RoepePaul DPDlld:pubmed
pubmed-article:18006157pubmed:authorpubmed-author:AmoahLinda...lld:pubmed
pubmed-article:18006157pubmed:authorpubmed-author:LekostajJacqu...lld:pubmed
pubmed-article:18006157pubmed:issnTypePrintlld:pubmed
pubmed-article:18006157pubmed:volume157lld:pubmed
pubmed-article:18006157pubmed:ownerNLMlld:pubmed
pubmed-article:18006157pubmed:authorsCompleteYlld:pubmed
pubmed-article:18006157pubmed:pagination107-11lld:pubmed
pubmed-article:18006157pubmed:dateRevised2011-9-26lld:pubmed
pubmed-article:18006157pubmed:meshHeadingpubmed-meshheading:18006157...lld:pubmed
pubmed-article:18006157pubmed:meshHeadingpubmed-meshheading:18006157...lld:pubmed
pubmed-article:18006157pubmed:meshHeadingpubmed-meshheading:18006157...lld:pubmed
pubmed-article:18006157pubmed:meshHeadingpubmed-meshheading:18006157...lld:pubmed
pubmed-article:18006157pubmed:meshHeadingpubmed-meshheading:18006157...lld:pubmed
pubmed-article:18006157pubmed:meshHeadingpubmed-meshheading:18006157...lld:pubmed
pubmed-article:18006157pubmed:meshHeadingpubmed-meshheading:18006157...lld:pubmed
pubmed-article:18006157pubmed:meshHeadingpubmed-meshheading:18006157...lld:pubmed
pubmed-article:18006157pubmed:year2008lld:pubmed
pubmed-article:18006157pubmed:articleTitleA single S1034C mutation confers altered drug sensitivity to PfMDR1 ATPase activity that is characteristic of the 7G8 isoform.lld:pubmed
pubmed-article:18006157pubmed:affiliationDepartment of Chemistry, Department of Biochemistry, Cellular & Molecular Biology, Lombardi Cancer Center, Georgetown University, 37th and O Streets, Washington, DC 20057, USA.lld:pubmed
pubmed-article:18006157pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18006157pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18006157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18006157lld:pubmed